{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:47:33Z","timestamp":1761058053585},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1990,10,1]],"date-time":"1990-10-01T00:00:00Z","timestamp":654739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1990,10]]},"DOI":"10.1007\/bf00315422","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T15:05:09Z","timestamp":1097593509000},"page":"413-415","source":"Crossref","is-referenced-by-count":38,"title":["Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia"],"prefix":"10.1007","volume":"39","author":[{"given":"P. N.","family":"Patsalos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Elyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","volume":"3","author":"M Dam","year":"1989","unstructured":"Dam M, Ekberg R, Loyning Y, Komulainen H, Riekaleinen PJ (1989) A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 3: 70?76","journal-title":"Epilepsy Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007691-198609000-00009","volume":"8","author":"AA Elyas","year":"1986","unstructured":"Elyas AA, Patsalos PN, Agbato OA, Brett EM, Lascelles PT (1986) Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10,11-epoxide in serum of children with epilepsy. Ther Drug Monit 8: 288?292","journal-title":"Ther Drug Monit"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0378-4347(00)82406-8","volume":"528","author":"AA Elyas","year":"1990","unstructured":"Elyas AA, Goldberg VD, Patsalos PN (1990) Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepine. J Chromatogr 528: 473?479","journal-title":"J Chromatogr"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000116315","volume":"26","author":"F Farago","year":"1987","unstructured":"Farago F (1987) Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol 26: 73?83","journal-title":"Eur Neurol"},{"key":"CR5","volume-title":"Advances in Epileptology. XIIth Epilepsy International Symposium","author":"KF Feldmann","year":"1981","unstructured":"Feldmann KF, Dorhofer G, Faigle JW, Imhof P (1981) Pharmacokinetics and metabolism of GP47779, the main human metabolite of oxcarbazepine in aminals and healthy volunteers. In: Dam M, Gram L, Penry JK (Eds) Advances in Epileptology. XIIth Epilepsy International Symposium. Raven, New York"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1987.tb03702.x","volume":"28","author":"MA Houtkooper","year":"1987","unstructured":"Houtkooper MA, Lammertsma A, Meyer JWA, Goedhart DM, Meinardi H, van Oorschot CEAH, Blom GF, Hoppener RJEA, Hulsman JARJ (1987) Oxcarbazepine (GP 47.680): A possible alternative to carbamazepine? Epilepsia 28: 693?698","journal-title":"Epilepsia"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00870993","volume":"31","author":"NA Klitgaard","year":"1986","unstructured":"Klitgaard NA, Kristensen O (1986) Use of saliva for monitoring oxcarbazepine therapy in epileptic patients. Eur J Clin Pharmacol 31: 91?94","journal-title":"Eur J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archneur.1979.00500370052010","volume":"36","author":"M Kosteljanetz","year":"1979","unstructured":"Kosteljanetz M, Christiansen J, Dam AM, Hansen BS, Lyon BB, Pedersen H, Dam M (1979) Carbamazepine versus phenytoin: a controlled clinical trial in focal motor and generalised epilepsy. Arch Neurol 36: 341?350","journal-title":"Arch Neurol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007691-198109000-00008","volume":"3","author":"L McKauge","year":"1981","unstructured":"McKauge L, Tyrer JH, Eadie MJ (1981) Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma. Ther Drug Monit 3: 63?70","journal-title":"Ther Drug Monit"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.26.10.936","volume":"26","author":"F Monaco","year":"1976","unstructured":"Monaco F, Riccio A, Benna P (1976) Further observations on carbamazepine plasma levels in epileptic patients. Neurology 26: 936?943","journal-title":"Neurology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0920-1211(87)90003-9","volume":"1","author":"KJ Reinikainen","year":"1987","unstructured":"Reinikainen KJ, Keranen T, Halonen T, Komulainen H, Riebkinen PJ (1987) Comparison of oxcarbazepine and carbamazepine: a double-blind study. Epilepsy Res 1: 284?289","journal-title":"Epilepsy Res"},{"issue":"88","key":"CR12","first-page":"115","volume":"64","author":"M Sillanpaa","year":"1981","unstructured":"Sillanpaa M (1981) Carbamazepine pharmacology and clinical use. Acta Neurol Scand 64 [Suppl 88]: 115?116","journal-title":"Acta Neurol Scand"},{"key":"CR13","first-page":"545","volume":"22","author":"M Theisohn","year":"1982","unstructured":"Theisohn M, Heimann G (1982) Disposition of the antiepileptic oxcarbazepine and its metabolite in healthy volunteers. Eur J Pharmacol 22: 545?551","journal-title":"Eur J Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archneur.1980.00500600047009","volume":"37","author":"T Tomson","year":"1980","unstructured":"Tomson T, Tybring G, Bertilsson L, Ekbon K, Rane A (1980) Carbamazepine therapy in trigeminal neuralgia. Clinical effects in relation to plasma concentration. Arch Neurol 37: 699?703","journal-title":"Arch Neurol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0091-6749(88)90059-0","volume":"82","author":"JM Zakrzewska","year":"1988","unstructured":"Zakrzewska JM, Ivanyi L (1988) In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10,11-epoxide and oxcarbazepine in the diagnosis of drug-induced hypersensitivity. J Allergy Clin Immun 82: 110?115","journal-title":"J Allergy Clin Immun"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jnnp.52.4.472","volume":"52","author":"JM Zakrzewska","year":"1989","unstructured":"Zakrzewska JM, Patsalos PN (1989) Oxcarbazepine ? a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiat 52: 422?476","journal-title":"J Neurol Neurosurg Psychiat"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00315422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00315422\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00315422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T19:08:52Z","timestamp":1554318532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00315422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["BF00315422"],"URL":"https:\/\/doi.org\/10.1007\/bf00315422","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}